Reining in recurrent Clostridium difficile infection--who's at risk?
Surawicz
Christina M
CM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000472:pathogenicity*; D024881:Drug Resistance, Bacterial; D004761:Enterocolitis, Pseudomembranous / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D012307:Risk Factors; D055502:Secondary Prevention; D012680:Sensitivity and Specificity
D000900:Anti-Bacterial Agents